TARDBP and amyotrophic lateral sclerosis: With regard to ALS, the observation that overexpression of Hsc70-4, its co-chaperone Csp⍺ or their client, dynamin, can rescue SV defects in TDP-43 models (Coyne et al. 2017) suggests that these proteins and their interactions could be potential therapeutic targets.